Company News

Dec. 5, 2011

DVS Sciences Appoints Joseph Victor as President and CEO

Jul. 14, 2011

DVS Sciences Raises $14.6 Million in Series A Financing

Jul. 14, 2011

DVS Sciences recognized as Momentum Company of the Year by the York Technology Alliance

May 6, 2011

Science Publication Describes Novel Biology Discovered through the Use of the CyTOF^® Mass Cytometer and Massively Multi-parametric Single Cell Analysis

Apr. 16, 2010

Massively Multi-parameter Single Cell Analysis by Mass Cytometry

Mar. 5, 2010

We are proud to inform you that DVSSciences Inc. is now represented in Asia by IAS Inc.

Nov. 1, 2009 Scott Tanner's presentation at the "Future of Medicine" conference
[ Windows Media Player ] [ QuickTime ] Nov. 17, 2009

DVS Sciences Unveils First-in-Class Mass Cytometer for Use in Understanding and Diagnosing Disease

Media Coverage

January 1, 2012CyTOF selected as one of Top 10 Innovations of 2011

December 1, 2011

DVS Sciences' technology is highlighted in a technology update in The Scientist: Richard P. Grant, "Flow Cytometry for the Masses", The Scientist Nov.Dec 2011

September 13, 2011DVS Sciences' technology is highlighted in the University of Toronto Magazine

May 31, 2011DVS: A made-in-Ontario success story for biotech

May 25, 2011U of T spinoff poised to revolutionize our understanding of disease

May 21, 2011

Univ. of Toronto Spinout Rolls Out New Biomarker System with Eye on Bead Array Market

May 16, 2011A Giant Leap for Cell Analysis

May 13, 2011

Stanford Team Uses DVS Sciences‘ CyTOF for Massive Hematopoietic Cell Protein Signaling

May 2011Mass Cytometry – Cell Detection’s New Frontier

March 17, 2011CyTOF Mass Spectrometer Used to Study Single Cells

March 4, 2011

Q&A: University of Toronto's Scott Tanner on the Use of Atomic Mass Spectrometry in Proteomics

Nov. 5, 2010EBB AND FLOW: Cytometry For The Next Generation

Nov. 2, 2010New Era of Cytometry, HTX

Apr. 29, 2010 U of T, partner hospitals receive $85.9M for genomics research

Jan. 13, 2010Ontario's Technologies Show Considerable Promise

May 21, 2008OICR invests $500,000 in new technology to identify cancer biomarkers

Download Images

CyTOF Instrument
High Resolution CyTOF Instrument
Low Resolution